Racial and ethnic differences in incident myocardial infarction in end-stage renal disease patients: The USRDS

Kidney International

Volumn 69, Issue 9, 2006, Pages 1691-1698

  Young, B A ^a,b,c   Rudser, K ^d   Kestenbaum, B ^a,b   Seliger, S L ^e   Andress, D ^a,b   Boyko, E J ^a,b  

^a VA PUGET SOUND HEALTH CARE SYSTEM   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c Northwest Kidney Centers   (United States)

^d UNIVERSITY OF WASHINGTON   (United States)

^e UNIVERSITY OF MARYLAND   (United States)

Author keywords

Dialysis; ESRD; Mortality; Myocardial infarction; Race; Transplant

Indexed keywords

ADULT; AFRICAN AMERICAN; AGED; ARTICLE; ASIAN AMERICAN; CARDIOVASCULAR RISK; CAUCASIAN; COHORT ANALYSIS; DIALYSIS; ETHNIC DIFFERENCE; FATALITY; FEMALE; HEALTH CARE ACCESS; HEART INFARCTION; HIGH RISK POPULATION; HISPANIC; HUMAN; INCIDENCE; KIDNEY FAILURE; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MEDICARE; MORTALITY; PREVALENCE; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; RACE DIFFERENCE; RENAL REPLACEMENT THERAPY;

ADULT; AGED; ETHNIC GROUPS; FEMALE; HUMANS; INCIDENCE; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; RISK; UNITED STATES;

EID: 33646528910     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/sj.ki.5000346     Document Type: Article

References (36)

1. USRDS 2005 Annual Data Report. Atlas of End-Stage Renal Disease in the United States. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases: Bethesda, MD 2002.
2. Levey AS, Beto JA, Coronado BE et al. Controlling the epidemic of cardiovascular disease in chronic renal disease: what do we know? What do we need to learn? Where do we go from here? National Kidney Foundation Task Force on Cardiovascular Disease. Am J Kidney Dis 1998; 32: 853-906.
3. Weiner DE, Tighiouart H, Amin MG et al. Chronic kidney disease as a risk factor for cardiovascular disease and all-cause mortality: a pooled analysis of community-based studies. J Am Soc Nephrol 2004; 15: 1307-1315.
4. Trespalacios FC, Taylor AJ, Agodoa LY, Abbott KC. Incident acute coronary syndromes in chronic dialysis patients in the United States. Kidney Int 2002; 62: 1799-1805.
5. Parekh RS, Zhang L, Fivush BA, Klag MJ. Incidence of atherosclerosis by race in the Dialysis Morbidity and Mortality Study: a sample of the US ESRD population. J Am Soc Nephrol 2005; 16: 1420-1426.
6. Conigliaro J, Whittle J, Good CB et al. Understanding racial variation in the use of coronary revascularization procedures: the role of clinical factors. Arch Intern Med 2000; 160: 1329-1335.
7. Wenneker MB, Epstein AM. Racial inequalities in the use of procedures for patients with ischemic heart disease in Massachusetts. JAMA 1989; 261: 253-257.
8. Whittle J, Conigliaro J, Good CB, Lofgren RP. Racial differences in the use of invasive cardiovascular procedures in the Department of Veterans Affairs Medical System. N Engl J Med 1993; 329: 621-627.
9. Weitzman S, Cooper L, Chambless L et al. Gender, racial, and geographic differences in the performance of cardiac diagnostic and therapeutic procedures for hospitalized acute myocardial infarction in four states. Am J Cordiol 1997; 79: 722-726.
10. Whittle J, Conigliaro J, Good CB, Joswiak M. Do patient preferences contribute to racial differences in cardiovascular procedure use? J Gen Intern Med 1997; 12: 267-273.
11. Petersen LA, Wright SM, Peterson ED, Daley J. Impact of race on cardiac care and outcomes in veterans with acute myocardial infarction. Med Care 2002; 40: 86-96.
12. Maynard C, Every NR, Martin JS, Weaver WD. Long-term implications of racial differences in the use of revascularization procedures (the Myocardial Infarction Triage and Intervention registry). Am Heart J 1997; 133: 656-662.
13. Daumit GL, Hermann JA, Coresh J, Powe NR. Use of cardiovascular procedures among black persons and white persons: a 7-year nationwide study in patients with renal disease. Ann Intern Med 1999; 130: 173-182.
14. Ganesh SK, Hulbert-Shearon T, Port FK et al. Mortality differences by dialysis modality among incident ESRD patients with and without coronary artery disease. J Am Soc Nephrol 2003; 14: 415-424.
15. Karter AJ, Ferrara A, Liu JY et al. Ethnic disparities in diabetic complications in an insured population. JAMA 2002; 287: 2519-2527.
16. Young BA, Maynard C, Boyko EJ. Racial differences in diabetic nephropathy, cardiovascular disease, and mortality in a national population of veterans. Diabetes Care 2003; 26: 2392-2399.
17. Khurana C, Rosenbaum CG, Howard BV et al. Coronary artery calcification in black women and white women. Am Heart J 2003; 145: 724-729.
18. Bild DE, Folsom AR, Lowe LP et al. Prevalence and correlates of coronary calcification in black and white young adults: the Coronary Artery Risk Development in Young Adults (CARDIA) Study. Arterioscler Thromb Vasc Biol 2001; 21: 852-857.
19. Newman AB, Naydeck BL, Sutton-Tyrrell K et al. Coronary artery calcification in older adults to age 99: prevalence and risk factors. Circulation 2001; 104: 2679-2684.
20. Lee TC, O'Malley PG, Feuerstein I, Taylor AJ. The prevalence and severity of coronary artery calcification on coronary artery computed tomography in black and white subjects. J Am Coll Cardiol 2003; 41: 39-44.
21. Barnhart JM, Fang J, Alderman MH. Differential use of coronary revascularization and hospital mortality following acute myocardial infarction. Arch Intern Med 2003; 163: 461-466.
22. Klag MJ, Whelton PK, Randall BL et al. Blood pressure and end-stage renal disease in men. N Engl J Med 1996; 334: 13-18.
23. Klag MJ, Whelton PK, Randall BL et al. End-stage renal disease in African-American and white men 16 year MRFIT findings. JAMA 1997; 277: 1293-1298.
24. Schulman KA, Berlin JA, Harless W et al. The effect of race and sex on physicians' recommendations for cardiac catheterization. N Engl J Med 1999; 340: 618-626.
25. Foley RN, Murray AM, Li S et al. Chronic kidney disease and the risk for cardiovascular disease, renal replacement, and death in the United States Medicare population, 1998 to 1999. J Am Soc Nephrol 2005; 16: 489-495.
26. Langefeld CD, Beck SR, Bowden DW et al. Heritability of GFR and albuminuria in Caucasians with type 2 diabetes mellitus. Am J Kidney Dis 2004; 43: 796-800.
27. De Boer IH, Gorodetskaya I, Young B et al. The severity of secondary hyperparathyroidism in chronic renal insufficiency is GFR-dependent, race-dependent, and associated with cardiovascular disease. J Am Soc Nephrol 2002; 13: 2762-2769.
28. Freedman BI, Bowden DW. The role of genetic factors in the development of end-stage renal disease. Curr Opin Nephrol Hypertens 1995; 4: 230-234.
29. Freedman BI, Wilson CH, Spray BJ et al. Familial clustering of end-stage renal disease in blacks with lupus nephritis. Am J Kidney Dis 1997; 29: 729-732.
30. Freedman BI, Yu H, Spray BJ et al. Genetic linkage analysis of growth factor loci and end-stage renal disease in African Americans. Kidney Int 1997; 51: 819-825.
31. Freedman BI, Bowden DW, Rich SS, Appel RG. Genetic initiation of hypertensive and diabetic nephropathy. Am J Hypertens 1998; 11: 251-257.
32. Fung F, Sherrard DJ, Gillen DL et al. Increased risk for cardiovascular mortality among malnourished end-stage renal disease patients. Am J Kidney Dis 2002; 40: 307-314.
33. Anonymous. U.S. Renal Data System: excerpts from the USRDS 2000 Annual Data Report: atlas of end-stage renal disease in the United States. Am J Kidney Dis 2000; 36: S1-S238.
34. Anonymous. Physician ICD-9-CM. Medicode Publications: Salt Lake City, UT, 1999.
35. Fisher L, Van Belle G. Biostatistics: A Methodology for the Health Sciences. Wiley New York, NY, 1993.
36. Cox D. Regression models and life tables. J R Stat Soc B 1972; 34: 187-220.